Literature DB >> 24253388

[Chronic periaortitis].

J H Schirmer1, M Both, F Moosig.   

Abstract

Chronic periaortitis is an inflammatory and fibrosing disease presenting as periaortal fibrosis and formation of aortic aneurysms which are mostly localized in the retroperitoneum and occasionally in the mediastinum. Inflammatory vasculitic involvement of large vessels is also possible. In addition to symptoms of systemic inflammation, mechanical complications also occur whereby obstruction of the ureter is the most frequent. The diagnosis is made by contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) and if the findings are atypical the diagnosis should be confirmed by biopsy. After exclusion of a secondary genesis, in which case therapy of the underlying illness would be necessary, idiopathic chronic periaortitis can be treated with steroids. In cases of refractory and relapsing courses the administration of further immunosuppressive medication can be necessary. Duration of therapy, dosage and indications for immunosuppressive medication are currently unclear and have to be defined in further randomized controlled trials with larger cohorts. If complications occur, interventional or operative treatment can be necessary; in cases of hydronephrosis the placement of double-J-stents is usually sufficient.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24253388     DOI: 10.1007/s00108-013-3297-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  30 in total

1.  Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases.

Authors:  Renzo Marcolongo; Ivan Matteo Tavolini; Francesco Laveder; Moira Busa; Franco Noventa; Pierfrancesco Bassi; Gianpietro Semenzato
Journal:  Am J Med       Date:  2004-02-01       Impact factor: 4.965

2.  Fifteen-year experience of transperitoneal management of inflammatory abdominal aortic aneurysms.

Authors:  S Sultan; S Duffy; P Madhavan; M P Colgan; D Moore; G Shanik
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-12       Impact factor: 7.069

3.  Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis.

Authors:  D Corradi; R Maestri; A Palmisano; S Bosio; P Greco; L Manenti; S Ferretti; R Cobelli; G Moroni; A P Dei Tos; C Buzio; A Vaglio
Journal:  Kidney Int       Date:  2007-07-11       Impact factor: 10.612

4.  Treatment of idiopathic retroperitoneal fibrosis using cyclosporin.

Authors:  A Marzano; A Trapani; N Leone; G C Actis; M Rizzetto
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  Value of various treatments for retroperitoneal fibrosis.

Authors:  L V Wagenknecht; J C Hardy
Journal:  Eur Urol       Date:  1981       Impact factor: 20.096

Review 6.  Chronic periaortitis: a spectrum of diseases.

Authors:  Augusto Vaglio; Carlo Buzio
Journal:  Curr Opin Rheumatol       Date:  2005-01       Impact factor: 5.006

Review 7.  Non-operative management of retroperitoneal fibrosis.

Authors:  P M Higgins; D N Bennett-Jones; P F Naish; G M Aber
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

8.  Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series.

Authors:  Jorge Vega; Helmuth Goecke; Héctor Tapia; Eduardo Labarca; Mario Santamarina; Gonzalo Martínez
Journal:  Am J Kidney Dis       Date:  2008-12-31       Impact factor: 8.860

9.  IgG4-Related Disease.

Authors:  John H Stone; John K C Chan; Vikram Deshpande; Kazuichi Okazaki; Hisanori Umehara; Yoh Zen
Journal:  Int J Rheumatol       Date:  2013-01-16

10.  Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease.

Authors:  Arezou Khosroshahi; Mollie N Carruthers; John H Stone; Shweta Shinagare; Nisha Sainani; Robert P Hasserjian; Vikram Deshpande
Journal:  Medicine (Baltimore)       Date:  2013-03       Impact factor: 1.889

View more
  1 in total

1.  Diffusion-weighted MRI in the follow-up of chronic periaortitis.

Authors:  L Kamper; P Haage; A S Brandt; W Piroth; N Abanador-Kamper; S Roth; H Ekamp
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.